Volume 272, Number 46,
Issue of November 14, 1997
pp. 29005-29014
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Inhibition of CD4 Translation Mediated by Human Immunodeficiency
Virus Type 1 Envelope Protein in a Cell-free System
(Received for publication, July 10, 1997, and in revised form, August 24, 1997)
Stephan
Bour
,
Romas
Geleziunas
and
Mark A.
Wainberg
From the McGill University AIDS Centre, Lady Davis Institute-Jewish
General Hospital, Montréal, Québec H3T 1E2, Canada
The human immunodeficiency virus type 1 (HIV-1)
employs a number of complex strategies to interfere with the synthesis,
stability, and subcellular localization of its specific cellular
receptor CD4. To define better the mechanisms of inhibition of CD4
expression, we used a rabbit reticulocyte lysate in vitro
system, in which cDNAs derived from HIV-1-infected cells were used
to generate mRNA for the Tat, Vpu, and gp160 envelope proteins that
were translated together with CD4-encoding mRNA. In the presence of
microsomal membranes, we observed that cotranslation of Env mRNA
resulted in a dose-dependent inhibition of CD4 translation.
This effect was enhanced further when an mRNA-encoding Vpu in
addition to Env mRNA was utilized. However, the activity of Vpu was
mostly post-translational, since translation of Vpu alone, but not Env, was able to destabilize CD4 molecules presynthesized into microsomes. The Env-mediated inhibitory effect was specifically targeted at CD4 and
did not affect the synthesis or stability of the CD8 molecule. Interestingly, mutated CD4 species, with a 20-fold lower affinity for
HIV-1 Env than wild-type, were less sensitive to cotranslational inhibition. Our report identifies the envelope as the HIV-1 protein responsible for down-regulation of CD4 translation. We further propose
a mechanism whereby direct interactions between gp160 and nascent CD4
molecules can cause interference with and premature termination of CD4
protein elongation.